Breaking News

Amgen Appoints Chief Compliance Officer

October 12, 2012

Patton brings 20 years of healthcare experience

Cynthia M. Patton has been appointed senior vice president and chief compliance officer at Amgen. Ms. Patton reports to Robert A. Bradway, president and chief executive officer, and will be responsible for Amgen's worldwide compliance and business ethics organization. She succeeds Anna Richo, who has resigned from the company to join another global biopharmaceutical company as general counsel.

Ms. Patton joined Amgen in 2005 and most recently served as vice president in the Amgen law department with responsibility for commercial legal activities in the U.S. Previously, she served as the lead commercial lawyer for both the oncology and inflammation business units. Prior to joining the company, she served for seven years as the general counsel of a California HMO.

"Cynthia has more than 20 years of healthcare legal experience and a deep understanding of our business operations," said Mr. Bradway. "Cynthia's addition to Amgen's leadership team will help us further our commitment to conduct business ethically and in compliance with the laws and regulations that govern our business and industry."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks